INDV

#1473
Indivior Pharmaceuticals, Inc. Common Stock
32.2450 USD
+2.04%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
31.8800
32.2450
Range Annuel
27.6800
36.0300
Changement quotidien
+2.04%
Changement Mensuel
+2.46%
Evolution sur 6 mois
-4.03%
Changement Annuel
-4.03%
Clôture Précédente
31.6000
Open
32.0300
Bid
Ask
Low
31.8800
High
32.2450
Volume
46
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
  • Market Capitalization 4.0327 B
  • Employee 838
  • Founded 2014
  • CEO Mark Crossley
  • Website www.indivior.com
  • Headquarter Delaware, United States
  • FIGI BBG01ZTXFLQ6
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
21.88
Price to sales ratio
3.71

Indivior Pharmaceuticals Inc

Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.

Nouvelles